XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities        
Net increase (decrease) in net assets resulting from operations $ 6,042,089 $ (4,092,470) $ 3,234,503 $ 2,586,630
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:        
Origination and purchase of investments (23,516,420) (62,524,462) (51,269,621) (144,746,910)
Payment in-kind interest and dividends (2,785,373) (2,870,741) (1,968,260) (633,752)
Sales and repayments of investments 22,952,501 92,303,435 61,928,745 153,877,788
Net realized (gain) loss on investments 8,114,711 13,971,537 26,890,095 14,395,431
Net change in unrealized appreciation/depreciation on investments (11,010,561) (3,287,977) (20,696,532) (8,058,117)
Amortization of discount/premium on investments (802,286) (2,049,993) (1,311,770) (2,662,806)
Amortization of deferred debt issuance costs 306,004 576,474 693,333 621,111
Amortization of original issue discount 35,555 71,110 71,110 71,110
Net (increase) decrease in operating assets:        
Interest receivable (274,865) 740,361 256,566 203,148
Payment-in-kind interest receivable (18,774) (20,537) (43,951) 39,610
Principal receivable (670,246) 42,972 741,462 5,040,250
Long-term receivable 142,302 (631,667) 0 0
Escrow receivable 97,173 (97,173) 0 0
Short-term receivable (160,901) 0 0 0
Other receivables 0 1,050 (1,050) 427,208
Prepaid expenses and other assets 314,497 (50,102) 48,682 (34,204)
Net increase (decrease) in operating liabilities:        
Payable for investments purchased (5,950,323) 5,629,703 1,548,313 246,984
Interest payable (56,004) (342,841) 719,410 624,996
Directors fees payable 81,323 (15,755) (5,025) (8,079)
Accrued expenses and other liabilities 71,831 240,189 (375,015) (294,737)
Base management fees payable (47,601) (89,441) (147,845) (16,517)
Income-based incentive fees payable 373,079 (447,147) 393,928 (465,790)
Net cash (used in) provided by operating activities (6,762,289) 37,056,525 20,707,078 21,213,354
Cash Flows from Financing Activities:        
Payments for deferred financing costs (20,549) (1,010,788) 0 (1,300,000)
Issuance of common shares 0 0 0 3,141,576
Distributions to stockholders (1,721,419) (11,188,149) (8,610,939) (8,505,056)
Repayments of Term loan 0 0 0 (102,000,000)
Proceeds from borrowing on revolving financing facility 15,500,000 37,100,000 46,900,000 182,835,346
Repayments of borrowing on revolving financing facility 0 (66,000,000) (59,000,000) (98,835,346)
Net cash (used in) provided by financing activities 13,758,032 (41,098,937) (20,710,939) (24,663,480)
Net change in cash 6,995,743 (4,042,412) (3,861) (3,450,126)
Cash:        
Cash and restricted cash at beginning of year 5,108,804 9,151,216 9,155,077 12,605,203
Cash and restricted cash at end of period 12,104,547 5,108,804 9,151,216 9,155,077
Supplemental and non-cash financing cash flow information:        
Cash paid for interest 3,808,417 8,949,150 7,693,998 6,008,590
Cash paid for taxes 0 267,150 294,330 270,618
Issuance of shares pursuant to Dividend Reinvestment Plan 7,031 40,213 21,749 56,093
Non-cash purchase of investments (29,716,835) (37,002,608) (16,865,488) (2,903,400)
Non-cash sale of investments 29,716,835 37,002,608 16,865,488 2,903,400
Cash 771,483 158,768 1,093,758 2,550,021
Cash, restricted 11,333,064 4,950,036 8,057,458 6,605,056
Cash and restricted cash $ 12,104,547 $ 5,108,804 $ 9,151,216 $ 9,155,077